Log In
BCIQ
Print this Print this
 

ARGX-113

  Manage Alerts
Collapse Summary General Information
Company argenx N.V.
DescriptionHuman antibody Fc fragment developed using ABDEG technology
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today